| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.6 | 0.03 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |